JOANNA KURILLA: Open Payments
NPI 1760052310 · MARYVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$705 in 34 payments from 11 companies in 2025. Trend: 2023 $617 · 2024 $392 · 2025 $705
Food & beverage: $668Education: $38
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 17 | $367 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| ABBVIE INC. | 2 | $49 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| Axsome Therapeutics, Inc. | 3 | $46 |
| Lilly USA, LLC | 1 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
| LivaNova USA, Inc. | 1 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
Products named: Qelbree, REXULTI, VRAYLAR, COBENFY, ZEPBOUND, Auvelity, CAPLYTA, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR.
Industry payments across IL — which companies pay providers there.
